BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 10892714)

  • 21. Primary cutaneous marginal zone B-cell lymphoma: a recently described entity of low-grade malignant cutaneous B-cell lymphoma.
    Cerroni L; Signoretti S; Höfler G; Annessi G; Pütz B; Lackinger E; Metze D; Giannetti A; Kerl H
    Am J Surg Pathol; 1997 Nov; 21(11):1307-15. PubMed ID: 9351568
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Therapy of primary cutaneous B-cell lymphomas].
    Zenahlik P; Fink-Puches R; Kapp KS; Kerl H; Cerroni L
    Hautarzt; 2000 Jan; 51(1):19-24. PubMed ID: 10663035
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Primary cutaneous B-cell lymphomas. Current concepts. I.
    Santucci M; Pimpinelli N
    Haematologica; 2004 Nov; 89(11):1360-71. PubMed ID: 15531459
    [TBL] [Abstract][Full Text] [Related]  

  • 24. PD-1, S-100 and CD1a expression in pseudolymphomatous folliculitis, primary cutaneous marginal zone B-cell lymphoma (MALT lymphoma) and cutaneous lymphoid hyperplasia.
    Goyal A; Moore JB; Gimbel D; Carter JB; Kroshinsky D; Ferry JA; Harris NL; Duncan LM
    J Cutan Pathol; 2015 Jan; 42(1):6-15. PubMed ID: 25384543
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Primary Cutaneous B-Cell Lymphoma: Management and Patterns of Recurrence at the Multimodality Cutaneous Lymphoma Clinic of The Ohio State University.
    Haverkos B; Tyler K; Gru AA; Winardi FK; Frederickson J; Hastings J; Elkins C; Zhang X; Xu-Welliver M; Wong HK; Porcu P
    Oncologist; 2015 Oct; 20(10):1161-6. PubMed ID: 26306900
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Primary cutaneous marginal zone B-cell lymphoma: clinical and histological aspects.
    Khaled A; Sassi S; Fazaa B; Ben Hassouna J; Ben Romdhane K; Kamoun MR
    Pathologica; 2009 Feb; 101(1):18-20. PubMed ID: 19771768
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diffuse low-grade B-cell lymphomas. Four clinically distinct subtypes defined by a combination of morphologic and immunophenotypic features.
    Zukerberg LR; Medeiros LJ; Ferry JA; Harris NL
    Am J Clin Pathol; 1993 Oct; 100(4):373-85. PubMed ID: 8213632
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Primary cutaneous follicle center cell lymphomas and large B cell lymphomas of the leg descend from germinal center cells. A single cell polymerase chain reaction analysis.
    Gellrich S; Rutz S; Golembowski S; Jacobs C; von Zimmermann M; Lorenz P; Audring H; Muche M; Sterry W; Jahn S
    J Invest Dermatol; 2001 Dec; 117(6):1512-20. PubMed ID: 11886516
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Primary cutaneous follicle center lymphoma in a 16-year-old girl.
    Edmonds N; Hernández-Pérez M; Holsinger M; Gru AA
    J Cutan Pathol; 2021 May; 48(5):663-668. PubMed ID: 33326136
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Navigating the cutaneous B-cell lymphomas: avoiding the rocky shoals.
    Jaffe ES
    Mod Pathol; 2020 Jan; 33(Suppl 1):96-106. PubMed ID: 31653979
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Frequency of central nervous system involvement in primary cutaneous B-cell lymphoma.
    Bekkenk MW; Postma TJ; Meijer CJ; Willemze R
    Cancer; 2000 Aug; 89(4):913-9. PubMed ID: 10951357
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Progression of cutaneous B-cell pseudolymphoma to cutaneous B-cell lymphoma.
    Kulow BF; Cualing H; Steele P; VanHorn J; Breneman JC; Mutasim DF; Breneman DL
    J Cutan Med Surg; 2002; 6(6):519-28. PubMed ID: 12404039
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cutaneous lymphomas: an update. Part 2: B-cell lymphomas and related conditions.
    Kempf W; Kazakov DV; Mitteldorf C
    Am J Dermatopathol; 2014 Mar; 36(3):197-208; quiz 209-10. PubMed ID: 24658377
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Marginal zone B-cell lymphoma: A clinical comparison of nodal and mucosa-associated lymphoid tissue types. Non-Hodgkin's Lymphoma Classification Project.
    Nathwani BN; Anderson JR; Armitage JO; Cavalli F; Diebold J; Drachenberg MR; Harris NL; MacLennan KA; Müller-Hermelink HK; Ullrich FA; Weisenburger DD
    J Clin Oncol; 1999 Aug; 17(8):2486-92. PubMed ID: 10561313
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CD5 expression in a lymphoma of the mucosa-associated lymphoid tissue (MALT)-type as a marker for early dissemination and aggressive clinical behaviour.
    Wenzel C; Dieckmann K; Fiebiger W; Mannhalter C; Chott A; Raderer M
    Leuk Lymphoma; 2001 Aug; 42(4):823-9. PubMed ID: 11697516
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Secondary lymph node involvement from primary cutaneous large B-cell lymphoma of the leg: sentinel lymph nodectomy as a new strategy for staging circumscribed cutaneous lymphomas.
    Starz H; Balda BR; Bachter D; Büchels H; Vogt H
    Cancer; 1999 Jan; 85(1):199-207. PubMed ID: 9921993
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cutaneous lymphoid hyperplasia and cutaneous marginal zone lymphoma: comparison of morphologic and immunophenotypic features.
    Baldassano MF; Bailey EM; Ferry JA; Harris NL; Duncan LM
    Am J Surg Pathol; 1999 Jan; 23(1):88-96. PubMed ID: 9888708
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Early detection of cutaneous lymphoma.
    Abd-el-Baki J; Stefanato CM; Koh HK; Demierre MF; Foss FM
    Oncology (Williston Park); 1998 Oct; 12(10):1521-30; discussion 1532-4. PubMed ID: 9798206
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Primary cutaneous marginal zone B-cell lymphoma: a clinical, histopathological, immunophenotypic and molecular genetic study of 22 cases.
    Servitje O; Gallardo F; Estrach T; Pujol RM; Blanco A; Fernández-Sevilla A; Pétriz L; Peyrí J; Romagosa V
    Br J Dermatol; 2002 Dec; 147(6):1147-58. PubMed ID: 12452864
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Current concepts on cutaneous MALT lymphomas.
    Fernandez-Flores A
    Am J Dermatopathol; 2013 Jun; 35(4):477-84. PubMed ID: 23694824
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.